Cargando…
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching
Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the effica...
Autores principales: | Maddaluno, Marcella, Grassia, Gianluca, Di Lauro, Maria Vittoria, Parisi, Antonio, Maione, Francesco, Cicala, Carla, De Filippis, Daniele, Iuvone, Teresa, Guglielmotti, Angelo, Maffia, Pasquale, Mascolo, Nicola, Ialenti, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471825/ https://www.ncbi.nlm.nih.gov/pubmed/23077623 http://dx.doi.org/10.1371/journal.pone.0047464 |
Ejemplares similares
-
The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
por: Grassia, Gianluca, et al.
Publicado: (2009) -
Murine Aortic Smooth Muscle Cells Acquire, Though Fail to Present Exogenous Protein Antigens on Major Histocompatibility Complex Class II Molecules
por: Maddaluno, Marcella, et al.
Publicado: (2014) -
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012) -
Macrophage Autophagy in Atherosclerosis
por: Maiuri, Maria Chiara, et al.
Publicado: (2013) -
Perivascular mast cells regulate vein graft neointimal formation and remodeling
por: Wu, Junxi, et al.
Publicado: (2015)